The TSH Receptor is Linked with AP1 and NFκB Signaling in COS7 Cells

Abstract

In addition to it's classic coupling to Gs and Gq the TSHR was shown to also couple to further members of four G-protein families in membranes: G_s, G_q/11, G_i/0 and G_12/13. Moreover, GPCRs are able to stimulate mitogenic signaling pathways by switching the receptor coupling to different G-proteins or by interacting with scaffold proteins like β-arrestins. These findings lead to the assumption of additional mitogenic TSHR stimulated signaling pathways. Therefore, we systematically investigated whether the TSH receptor is able to stimulate signaling pathways apart from the known cAMP and IP pathways. We used a luciferase reporter gene assay containing response elements covering a variety of signal transduction pathways. After TSH-stimulation the TSHR showed a significantly increased CRE-, AP1- or NFκB-mediated luciferase accumulation in COS7 cells. No effect on luciferase accumulation was found for the other reporter gene vectors. These findings lead to the hypothesis of a possible relevance of AP1 and NFκB for TSHR-dependent signaling pathways in COS cells which act in addition to the known cAMP and IP pathways.

Key words

TSH receptor - reporter gene - luciferase - signaling pathway

References

• 1 Allgeier A, Offermanns S, Van Sande J, Spicher K, Schultz G, Dumont JE. The human thyrotropin receptor activates G-proteins Gs and Gq/11.  J Biol Chem. 1994;  269 13733-13735
• 2 Baillie GS, Sood A, McPhee I, Gall I, Perry SJ, Lefkowitz RJ, Houslay MD. beta-Arrestin-mediated PDE4 cAMP phosphodiesterase recruitment regulates beta-adrenoceptor switching from Gs to Gi.  Proc Natl Acad Sci USA. 2003;  100 940-945
• 3 Cetani F, Tonacchera M, Vassart G. Differential effects of NaCl concentration on the constitutive activity of the thyrotropin and the luteinizing hormone/chorionic gonadotropin receptors.  FEBS Lett. 1996;  378 27-31
• 4 Corvilain B, Laurent E, Lecomte M, Vansande J, Dumont JE. Role of the cyclic adenosine 3′, 5′-monophosphate and the phosphatidylinositol-Ca2+ cascades in mediating the effects of thyrotropin and iodide on hormone synthesis and secretion in human thyroid slices.  J Clin Endocrinol Metab. 1994;  79 152-159
• 5 Daaka Y, Luttrell LM, Lefkowitz RJ. Switching of the coupling of the beta2-adrenergic receptor to different G proteins by protein kinase A.  Nature. 1997;  390 88-91
• 6 Gudermann T, Grosse R, Schultz G. Contribution of receptor/G protein signaling to cell growth and transformation.  Naunyn Schmiedebergs Arch Pharmacol. 2000;  361 345-362
• 7 Gudermann T, Nurnberg B, Schultz G. Receptors and G proteins as primary components of transmembrane signal transduction. Part 1. G-protein-coupled receptors: structure and function.  J Mol Med. 1995;  73 51-63
• 8 Gurevich EV, Gurevich VV. Arrestins: ubiquitous regulators of cellular signaling pathways.  Genome Biol. 2006;  7 236
• 9 Iacovelli L, Capobianco L, Salvatore L, Sallese M, D'Ancona GM, De Blasi A. Thyrotropin activates mitogen-activated protein kinase pathway in FRTL-5 by a cAMP-dependent protein kinase A-independent mechanism.  Mol Pharmacol. 2001;  60 924-933
• 10 Ji TH, Grossmann M, Ji I. G protein-coupled receptors. I. Diversity of receptor-ligand interactions.  J Biol Chem. 1998;  273 17299-17302
• 11 Laugwitz KL, Allgeier A, Offermanns S, Spicher K, Van Sande J, Dumont JE, Schultz G. The human thyrotropin receptor: a heptahelical receptor capable of stimulating members of all four G protein families.  Proc Natl Acad Sci USA. 1996;  93 116-120
• 12 Lefkowitz RJ, Shenoy SK. Transduction of receptor signals by beta-arrestins.  Science. 2005;  308 512-517
• 13 Liebmann C. Regulation of MAP kinase activity by peptide receptor signalling pathway: paradigms of multiplicity.  Cell Signal. 2001;  13 777-785
• 14 Lopez-Ilasaca M. Signaling from G-protein-coupled receptors to mitogen-activated protein (MAP)-kinase cascades.  Biochem Pharmacol. 1998;  56 269-277
• 15 Luttrell LM, Ferguson SS, Daaka Y, Miller WE, Maudsley S, Della RG, Lin F, Kawakatsu H, Owada K, Luttrell DK, Caron MG, Lefkowitz RJ. Beta-arrestin-dependent formation of beta2 adrenergic receptor-Src protein kinase complexes.  Science. 1999;  283 655-661
• 16 Luttrell LM, Roudabush FL, Choy EW, Miller WE, Field ME, Pierce KL, Lefkowitz RJ. Activation and targeting of extracellular signal-regulated kinases by beta -arrestin scaffolds.  Proc Natl Acad Sci USA. 2001;  98 2449-2454
• 17 Marinissen MJ, Gutkind JS. G-protein-coupled receptors and signaling networks: emerging paradigms.  Trends Pharmacol Sci. 2001;  22 368-376
• 18 McDonald PH, Chow CW, Miller WE, Laporte SA, Field ME, Lin FT, Davis RJ, Lefkowitz RJ. beta-arrestin 2: A receptor-regulated MAPK scaffold for the activation of JNK3.  Science. 2000;  290 1574-1577
• 19 Nagayama Y, Rapoport B. The thyrotropin receptor 25 years after its discovery: new insight after its molecular cloning.  Mol Endocrinol. 1992;  6 145-156
• 20 Pacifico F, Mauro C, Barone C, Crescenzi E, Mellone S, Monaco M, Chiappetta G, Terrazzano G, Liguoro D, Vito P, Consiglio E, Formisano S, Leonardi A. Oncogenic and anti-apoptotic activity of NF-kappa B in human thyroid carcinomas.  J Biol Chem. 2004;  279 54610-54619
• 21 Reddy SA, Huang JH, Liao WS. Phosphatidylinositol 3-kinase in interleukin 1 signaling. Physical interaction with the interleukin 1 receptor and requirement in NFkappaB and AP-1 activation.  J Biol Chem. 1997;  272 29167-29173
• 22 Saunier B, Tournier C, Jacquemin C, Pierre M. Stimulation of mitogen-activated protein kinase by thyrotropin in primary cultured human thyroid follicles.  J Biol Chem. 1995;  270 3693-3697
• 23 Schaaf L, Leiprecht A, Saji M, Hubner U, Usadel KH, Kohn LD. Glycosylation variants of human TSH selectively activate signal transduction pathways.  Mol Cell Endocrinol. 1997;  132 185-194
• 24 Segaloff DL, Ascoli M. The lutropin/choriogonadotropin receptor … 4 years later.  Endocr Rev. 1993;  14 324-347
• 25 Sprengel R, Braun T, Nikolics K, Segaloff DL, Seeburg PH. The testicular receptor for follicle stimulating hormone: structure and functional expression of cloned cDNA.  Mol Endocrinol. 1990;  4 525-530
• 26 Sun Y, Huang J, Xiang Y, Bastepe M, Juppner H, Kobilka BK, Zhang JJ, Huang XY. Dosage-dependent switch from G protein-coupled to G protein-independent signaling by a GPCR.  EMBO J. 2007;  26 53-64
• 27 Szkudlinski MW, Fremont V, Ronin C, Weintraub BD. Thyroid-stimulating hormone and thyroid-stimulating hormone receptor structure-function relationships.  Physiol Rev. 2002;  82 473-502
• 28 Taniguchi SI, Shong M, Giuliani C, Napolitano G, Saji M, Montani V, Suzuki K, Singer DS, Kohn LD. Iodide suppression of major histocompatibility class I gene expression in thyroid cells involves enhancer A and the transcription factor NF-kappa B.  Mol Endocrinol. 1998;  12 19-33
• 29 Van Sande J, Raspe E, Perret J, Lejeune C, Maenhaut C, Vassart G, Dumont JE. Thyrotropin activates both the cyclic AMP and the PIP2 cascades in CHO cells expressing the human cDNA of TSH receptor.  Mol Cell Endocrinol. 1990;  74 R1-R6
• 30 Vassart G, Dumont JE. The thyrotropin receptor and the regulation of thyrocyte function and growth.  Endocr Rev. 1992;  13 596-611
• 31 Visconti R, Cerutti J, Battista S, Fedele M, Trapasso F, Zeki K, Miano MP, de Nigris F, Casalino L, Curcio F, Santoro M, Fusco A. Expression of the neoplastic phenotype by human thyroid carcinoma cell lines requires NFkappaB p65 protein expression.  Oncogene. 1997;  15 1987-1994
• 32 Whitmarsh AJ, Davis RJ. Transcription factor AP-1 regulation by mitogen-activated protein kinase signal transduction pathways.  J Mol Med. 1996;  74 589-607
• 33 Wonerow P, Schoneberg T, Schultz G, Gudermann T, Paschke R. Deletions in the third intracellular loop of the thyrotropin receptor. A new mechanism for constitutive activation.  J Biol Chem. 1998;  273 7900-7905
• 34 Ye RD. Regulation of nuclear factor kappaB activation by G-protein-coupled receptors.  J Leukoc Biol. 2001;  70 839-848

Correspondence